Effect of anti-inflammatory agents on the haemorrhagic response of mouse skin to Bordetella pertussis heat-labile toxin

References

1. Barrie H. 1962; Treatment of whooping cough. Lancet 2:830–831
   [Google Scholar]
2. Bliss C I. 1967 Statistics in biology. vol. 1 McGraw-Hill, New York:
   [Google Scholar]
3. Broomhall J, Herxheimer A. 1984; Treatment of whooping cough: the facts. Archives of Disease in Childhood 59:185–187
   [Google Scholar]
4. Cowell J L, Hewlett E L, Manclark C R. 1979; Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infection and Immunity 25:896–901
   [Google Scholar]
5. Dayal R S, Atal P R, Kumar Y. 1969; A comparative study of different culture techniques and therapeutic efficacy of newer antibiotics in pertussis. Indian Journal of Medical Sciences 23:421–427
   [Google Scholar]
6. Dianese G. 1982; Treatment of whooping cough:. Lancet 2:1224
   [Google Scholar]
7. Hart F D, Huskisson E C. 1984; Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use. Drugs 27:232–255
   [Google Scholar]
8. Herbert D, Phipps P J, Strange RE. 1971 Chemical analysis of microbial cells. In Norris J R, Ribbons D W. (eds) Methods in microbiology vol. 5B Academic Press: London; pp 209344
   [Google Scholar]
9. Idigbe E O, Parton R, Wardlaw AC. 1981; Rapidity of antigenic modulation of Bordetella pertussis in modified Hornibrook medium. Journal of Medical Microbiology 14:409–418
   [Google Scholar]
10. Katsampes C P, Brooks A M, Bradford W L. 1942; Toxicity of washings from Hemophilus pertussis for mice. Proceedings of the Society for Experimental Biology and Medicine 49:615–618
    [Google Scholar]
11. Kurokawa M, Ishida S, Asakawa S. 1969; Attempts at analysis of toxicity of pertussis vaccine. II. Quantitative determination of the heat-labile toxin by skin reaction. Japanese Journal of Medical Science and Biology 22:293–307
    [Google Scholar]
12. Livey I, Wardlaw A C. 1984; Production and properties of Bordetella pertussis heat-labile toxin. Journal of Medical Microbiology 17:91–103
    [Google Scholar]
13. Miller C L, Fletcher W B. 1976; Severity of notified whooping cough. British Medical Journal 1:117–119
    [Google Scholar]
14. Munoz J. 1971 Protein toxins from Bordetella pertussis. In Kadis S, Montie T C, Ajl S J. (eds) Microbial toxins, voi Ila, Bacterial protein toxins Academic Press; New York: pp 271–300
    [Google Scholar]
15. Munoz J, Bergman R K. 1968; Histamine-sensitizing factors from microbial agents, with special reference to Bordetella pertussis. Bacteriological Reviews 32:103–126
    [Google Scholar]
16. Nakase Y, Endoh M. Bordetella heat-labile toxin: further purification, characterization and mode of action. Proceedings of the Fourth International Symposium on Pertussis, Geneva 1984 (in press)
    [Google Scholar]
17. Nakase Y, Takatsu K, Tateishi M, Sekiya K, Kasuga T. 1969; Heat-labile toxin of Bordetella pertussis purified by preparative acrylamide gel electophoresis. Japanese Journal of Microbiology 13:359–366
    [Google Scholar]
18. Nickander R, Mcmahon F G, Ridolfo A S. 1979; Nonsteroidal anti-inflammatory agents. Annual Review of Pharmacology and Toxicology 19:469–490
    [Google Scholar]
19. Olson L C. 1975; Pertussis. Medicine (Baltimore) 54:427–469
    [Google Scholar]
20. Onoue K, Kitagawa M, Yamamura Y. 1963; Chemical studies on cellular components of Bordetella pertussis. III. Isolation of highly potent toxin from Bordetella pertussis. Journal of Bacteriology 86:648–655
    [Google Scholar]
21. Parton R. 1985; Effect of prednisolone on the toxicity of Bordetella pertussis for mice. Journal of Medical Microbiology 19:391–400
    [Google Scholar]
22. Pittman M. 1979; Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Reviews of Infectious Diseases 1:401–412
    [Google Scholar]
23. Samuelsson B. 1983; Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568–575
    [Google Scholar]
24. Violle H. 1950; Sur le pouvoir dermo-nécrotique du bacille de la coqueluche. Bulletin Academiea Nationale de Médêcine (Paris) 134:518–521
    [Google Scholar]
25. Wardlaw A C, Parton R. 1983; Bordetella pertussis toxins. Pharmacology and Therapeutics 19:1–53
    [Google Scholar]
26. Wardlaw A C, Parton R, Hooker M J. 1976; Loss of protective antigen, histamine-sensitising factor and envelope polypeptides in cultural variants of Bordetella pertussis. Journal of Medical Microbiology 9:89–100
    [Google Scholar]
27. Zoumboulakis D, Anagnostakis D, Albanis V, Matsaniotis N. 1973; Steroids in treatment of pertussis: a controlled clinical trial. Archives of Disease in Childhood 48:51–54
    [Google Scholar]